Arcellx, Inc.
Arcellx, Inc. (ACLX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ACLX · as of Jun 8, 2026
Key Statistics
Explore Arcellx, Inc. Data
aclx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 38.9%
The ACLX analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $112.45, representing -2.28% downside from the current price of $115.07.
Competitors & Peers
aclx competitorsACLX
AKRO
ALKS
ARWR
CRSP
IMVTStock Performance
Full HistoryAbout Arcellx, Inc.
Arcellx, Inc. a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product can…
what is arcellx, inc. · aclx stock overview · arcellx, inc. company profile · who is arcellx, inc. ceo · aclx NASDAQ · arcellx, inc. headquarters · arcellx, inc. business segments
About Stock Overview & Key Data
Arcellx, Inc. (ACLX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 4, 2022. As of the latest trading session, ACLX stock price is $115.07, with a market capitalization of $6.7B. The stock has returned +72.11% over the past 12 months and +76.49% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Arcellx, Inc. stock is Hold, with an average 12-month price target of $112.45. In fiscal year 2025, Arcellx, Inc. reported revenue of $22.3M and net income of -$228.9M. For detailed data — including Arcellx, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arcellx, Inc. (ACLX) stock price is $115.07. The stock is traded on NASDAQ under the ticker symbol ACLX. The 52-week range is $50.85 – $115.13.